TC
TVM Capital Life Science
Venture CapitalModerateTVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany.
9
Investments
3
Exits
$1B
AUM
33.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for TVM Capital Life Science.
Investment Thesis & Strategy
TVM Capital Life Science invests in life science companies across various stages, with a focus on the healthcare sector. They seek to invest in companies with offices in Montreal, Canada and Munich, Germany.
Investment Activity
Deals per year over the last 19 years
1
20000
20010
20020
20030
20040
20050
20060
20070
20080
20091
20100
20110
20121
20131
20142
20151
20161
20172
2018Portfolio Companies
Selected investments from their portfolio of 9 companies
M
MAB Discovery
Biotech · Series A, 2018
I
Inositec
Biotech · Series A, 2018
i
iOmx Therapeutics
Biotech · Series B, 2017
A
AM-Pharma
Biotech · Series C+, 2016
O
ObsEva
Biotech · Series B, 2015
I
Immatics
Biotech · Series C+, 2015
R
Rigontec
Biotech · Series A, 2014
B
Biohaven Pharmaceutical
Biotech · Series A, 2013
S
Sutro Biopharma
Biotech · Series B, 2010
B
Bayerische Biotech
Biotech · Growth, 2000
Notable Exits
CompanyTypeYearValue / Acquirer
iOmx TherapeuticsAcquisition2024—
BiotestAcquisition2024—
AM-PharmaAcquisition2023$2.1B
Frequently Asked Questions
TVM Capital Life Science focuses on Series A, Series B, Series C+ stage investments.